The independent source for health policy research, polling, and news.
The Republican Health-care Plan the Country Isn’t Debating
In this Washington Post op-ed, Drew Altman discusses how Republicans’ ideas to change Medicaid and Medicare and repeal the Affordable Care Act would fundamentally change the federal role in health, calling it: the biggest change in health we are NOT debating.
Column Read PostJAMA Forum: What Might an ACA Replacement Plan Look Like?
Larry Levitt’s January 2017 post explains the logistics of a “repeal and delay” approach to the Affordable Care Act, and outlines key elements of a proposed replacement plan from Rep. Tom Price, who is President Trump’s nominee for Secretary of Health and Human Services. The post is now available at The JAMA Forum.
Column Read PostHigh-Risk Pools as Fallback for High-Cost Patients Require New Rules
In this Wall Street Journal Think Tank column, Drew Altman examines how Republicans would “split the risk pools” between the healthier and the sick in their Affordable Care Act replacement plans, using state high risk pools as a fallback for higher cost patients, and examines the steps that would be necessary to make them effective based on prior experience in the states.
Column Read PostObamacare Debate: Where GOP Governors Stand on Repeal and Replace
As congress prepares to vote on repeal of the Affordable Care Act, Drew Altman discusses whether Republican governors and congressional Republicans will be at odds over key issues when it comes to repealing and replacing the law in this Wall Street Journal Think Tank column.
Column Read PostThe Health Care Plan Trump Voters Really Want
In a New York Times op-ed, Drew Altman draws on observations from focus groups in rust belt states of people in the Affordable Care Act (ACA) marketplaces who voted for President-elect Trump and say they may not like their coverage under the ACA but could like Republican replacement plans even less.
Column Read PostUnderstanding Who Opioid Users Are Underscores Challenges
The 21st Century Cures Act provided a billion dollars in new funding for opioid prevention and treatment. In this Wall Street Journal Think Tank column, Drew Altman looks at the challenges based on a new Kaiser-Washington Post survey of long term opioid users.
Column Read Post